Authors: Ostlie, NS Karachunski, PI Wang, W Monfardini, C Kronenberg, M Conti-Fine, BM

Citation: Ns. Ostlie et al., Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis, J IMMUNOL, 166(8), 2001, pp. 4853-4862

Authors: Karachunski, PI Ostlie, NS Monfardini, C Conti-Fine, BM

Citation: Pi. Karachunski et al., Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice, J IMMUNOL, 164(10), 2000, pp. 5236-5244

Authors: Karachunski, PI Ostlie, NS Okita, DK Conti-Fine, BM

Citation: Pi. Karachunski et al., Interleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4(+) epitope sequences of the acetylcholine receptor, J NEUROIMM, 95(1-2), 1999, pp. 73-84

Authors: Karachunski, PI Ostlie, NS Okita, DK Garman, R Conti-Fine, BM

Citation: Pi. Karachunski et al., Subcutaneous administration of T-epitope sequences of the acetylcholine receptor prevents experimental myasthenia gravis, J NEUROIMM, 93(1-2), 1999, pp. 108-121

Authors: Wang, ZY Karachunski, PI Howard, JF Conti-Fine, BM

Citation: Zy. Wang et al., Myasthenia in SCID mice grafted with myasthenic patient lymphocytes - Roleof CD4(+) and CD8(+) cells, NEUROLOGY, 52(3), 1999, pp. 484-497